- Supported exchanges /
- KQ /
- 084990.KQ
Helixmith Co. Ltd (084990 KQ) stock market data APIs
Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological diseases. The company's pipeline products include VM206, a therapeutic cancer vaccine targeting HER2/neu positive breast or ovarian cancer; and VM501, a re-engineered form of interleukin 11 targeting chemotherapy-induced thrombocytopenia. Its clinical trials biologics comprise VM202-DPN, VM202-PAD, VM501, VM202-ALS, VM202-CAD, and VM206. The company was formerly known as ViroMed Co., Ltd. and changed its name to Helixmith Co., Ltd in April 2019. Helixmith Co., Ltd was incorporated in 1996 and is headquartered in Seoul, South Korea.
Helixmith Co. Ltd Financial Data Overview
| 3035 | |
| 3010 | |
| - | |
| 3080 | |
| 3010 | |
| 2995-7440 | |
| 140 904 M | |
| 15 956 K | |
| 2 892 M | |
| -82.4124 | |
| 0.8016 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Helixmith Co. Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 892 M
- EBITDA -45 603 438 592
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Helixmith Co. Ltd Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get Helixmith Co. Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
